Home > Income Statement > AARTI DRUGS

AARTI DRUGS
Revenue

    Back to Income Statement
AARTI DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹2,529 Cr₹2,716 Cr₹2,489 Cr₹2,155 Cr₹1,806 Cr

What is the latest Revenue of AARTI DRUGS ?

The latest Revenue ratio of AARTI DRUGS is ₹2,529 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹2,529 Cr
Mar2024₹2,716 Cr
Mar2023₹2,489 Cr
Mar2022₹2,155 Cr
Mar2021₹1,806 Cr

How is Revenue of AARTI DRUGS Trending?

Years Revenue % Change
Mar2025 ₹2,529 Cr
-6.90
Mar2024 ₹2,716 Cr
9.14
Mar2023 ₹2,489 Cr
15.49
Mar2022 ₹2,155 Cr
19.31
Mar2021 ₹1,806 Cr -

Compare Revenue of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹3,503.6 Cr 3.1% 0.8% -17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,048.0 Cr 0.5% 4.6% 11.7% Stock Analytics
DIVIS LABORATORIES ₹177,179.0 Cr -0.6% 2.2% -0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,804.0 Cr 3.2% 8.1% 43.9% Stock Analytics
CIPLA ₹117,642.0 Cr 1.1% 5.6% -3.5% Stock Analytics
DR REDDYS LABORATORIES ₹112,368.0 Cr -0.3% 5.6% -0.1% Stock Analytics


AARTI DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

3.1%

0.8%

-17%

SENSEX

0.7%

4.4%

-5.6%


You may also like the below Video Courses